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ABSTRACT
Objective: Diabetes mellitus (DM) and antibiotic resistance is an emerging public health problem in Ethiopia. 
Urinary tract infections (UTIs) are common and occasionally life- threatening condition among diabetic pa-
tients. Despite, all these problems, antibiotics are prescribed empirically which may adversely affect antibiotic 
resistance so far. Therefore the aim of this study was to identify the etiologic agents of UTI and their antibiotic 
resistance pattern among diabetic patients attending diabetic clinic of Hawassa University Referral Hospital. 
Material and methods: A cross-sectional study was conducted in a total of 240 diabetic patients from June 
to October, 2014. After obtaining an informed written consent, socio-demographic and clinical data were 
collected using pre-structured questionnaire. Clean catch mid-stream urine samples were collected and pro-
cessed for identification of uropathogen through culture using standard microbiologic procedure. Antibiotic 
susceptibility test was carried out using Kirby-Bauer disc diffusion method. 
Results: The overall prevalence of diabetic UTI was 13.8%. Out of the total number of patients, 11.2% and 
23.1% had asymptomatic and symptomatic bacteriuria respectively. DM patients with no previous history of UTI 
[AOR=3.55; 95% CI=1.186-10.611] and illiterate [AOR=2.5; 95% CI=1.052-5.989] had higher odds of UTI com-
pared with their counterparts. E. coli was the commonest isolated uropathogen followed by CoNS. All the isolated 
bacteria were resistant to ampicillin but sensitive to nitrofurantoin. Gram- negative isolates demonstrated high 
level of resistance to trimethoprim-sulphamethoxazole in 9 (81.8%), gentamicin in 8 (72.7%) and ceftriaxone in 7 
(63.6%) patients. Gram- positive bacteria showed resistance to penicillin in 14 (87.5%), norfloxacin in 10 (62.5%) 
and ciprofloxacin in 8(50.0%) patients. Multidrug resistance was observed in 93.9% of the isolated uropathogens.
Conclusion: Overall prevalence of diabetic UTI was 13.8%. Illiterate DM patients with no previous history 
of UTI were significantly associated with UTI. E. coli was the commonest isolated uropathogen. Nitrofu-
rantoin can be used as a drug of choice for empiric treatment of UTI in the study area. Multidrug resistance 
to commonly used antibiotics is an alarming phenomenon. Therefore, performing of urine cultures and 
periodic surveillance of UTI among DM patients is necessary.
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ÖZ
Amaç: Diabetes mellitus (DM) and antibiotic resistance is an emerging public health problem in Ethiopia. Uri-
nary tract infections (UTIs) are common and occasionally life- threatening condition among diabetic patients. 
Despite, all these problems, antibiotics are prescribed empirically which may adversely affect antibiotic resistance 
so far. Therefore the aim of this study was to identify the etiologic agents of UTI and their antibiotic resistance 
pattern among diabetic patients attending diabetic clinic of Hawassa University Referral Hospital. 
Gereç ve yöntemler: A cross-sectional study was conducted in a total of 240 diabetic patients from June 
to October, 2014. After obtaining an informed written consent, socio-demographic and clinical data were 
collected using pre-structured questionnaire. Clean catch mid-stream urine samples were collected and pro-
cessed for identification of uropathogen through culture using standard microbiologic procedure. Antibiotic 
susceptibility test was carried out using Kirby-Bauer disc diffusion method. 
Bulgular: The overall prevalence of diabetic UTI was 13.8%. Out of the total number of patients, 11.2% and 
23.1% had asymptomatic and symptomatic bacteriuria respectively. DM patients with no previous history of UTI 
[AOR=3.55; 95% CI=1.186-10.611] and illiterate [AOR=2.5; 95% CI=1.052-5.989] had higher odds of UTI compa-
red with their counterparts. E. coli was the commonest isolated uropathogen followed by CoNS. All the isolated 
bacteria were resistant to ampicillin but sensitive to nitrofurantoin. Gram- negative isolates demonstrated high 
level of resistance to trimethoprim-sulphamethoxazole in 9 (81.8%), gentamicin in 8 (72.7%) and ceftriaxone in 7 
(63.6%) patients. Gram- positive bacteria showed resistance to penicillin in 14 (87.5%), norfloxacin in 10 (62.5%) 
and ciprofloxacin in 8(50.0%) patients. Multidrug resistance was observed in 93.9% of the isolated uropathogens.
Sonuç: Overall prevalence of diabetic UTI was 13.8%. Illiterate DM patients with no previous history of 
UTI were significantly associated with UTI. E. coli was the commonest isolated uropathogen. Nitrofuran-
toin can be used as a drug of choice for empiric treatment of UTI in the study area. Multidrug resistance to 
commonly used antibiotics is an alarming phenomenon. Therefore, performing of urine cultures and perio-
dic surveillance of UTI among DM patients is necessary.
Anahtar Kelimeler: Antibiotic resistance; bacteriuria; diabetes mellitus; urinary tract infection.
Introduction
The prevalence of diabetes mellitus (DM) is alarmingly increas-
ing throughout the world and becoming a serious public health 
problem, especially in the developing countries.[1] Patients with 
DM are at increased risk for urinary tract infection (UTI).[2] The 
exact reason for this relationship remains unclear; however, few 
studies have reported that diabetic patients have immunologic 
impairment,[3] inadequate bladder emptying which necessitates 
subsequent urological manipulation predisposing to UTI.[4] 
Moreover, in addition to expression of different virulence fac-
tors, a higher glucose concentration in the urine may create a 
culture medium for the growth of pathogenic microorganisms.[4]
Urinary tract infections are generally asymptomatic in DM pa-
tients before development of symptomatic UTI.[5] Females are 
more commonly affected with UTI than males.[6] In addition, the 
prevalence of asymptomatic bacteriuria is higher among women 
with type II diabetes[7] which leads to serious complications es-
pecially if glycemic control is poor.[8] 
Several studies have showed that Escherichia coli, Klebsiella 
spp, Proteus spps, Group B Streptococcus, coagulase- negative 
Staphylococci (CoNS), S. aureus, Enterococcus spp, Enterobac-
ter spp., Citrobacter spp., Serratia spp, pseudomonas aerogi-
nosa and candidia spp. have been isolated among DM patients 
with a varying frequency.[9-13] 
Antibiotic resistance is a major global public health problem 
both for hospital and community- acquired infections.[14] The 
problem is challenging in low-income countries because of high 
prevalence of infection, irrational uses of antibiotics, over-the-
counter availability of antibiotics and poor infection prevention 
practices. Hence the emerging prevalence of antibiotic resis-
tance[15, 16] and DM in Ethiopia[17] is a cause of concern for health 
care providers. Therefore, retrieval of updated information on 
the spectrum of uropathogens and their antibiotic resistance pat-
terns in a specific hospital is mandatory. In few hospital- based 
studies conducted in the Central and Northwest part of Ethiopia 
reported incidence of antibiotic-resistance in UTI ranging be-
tween 10.4%, and 17.8%[9-11] and higher rate of multidrug resis-
tance varying between 59.8%, and 71.7%.[9,10] among diabetic 
patients. However, there is no study conducted on antibiotic-
resistance patterns in the Southern part of Ethiopia. Therefore 
this study was undertaken to identify the etiologic agents of UTI 
and their antibiotic resistance patterns among diabetic patients at 
Hawassa University Referral Hospital, Southern Ethiopia.
Material and methods
Study design and area
A cross-sectional study was conducted from June to October 
2014 at Hawassa University Referral Hospital, Southern Ethio-
pia. The hospital is a tertiary level teaching Hospital that pro-
vides health services to over six million inhabitants in southern 
Ethiopia and it is located 275 km south from the capital city, 
Addis Ababa.
Study subject 
Two hundred- forty DM patients visiting the hospital for their 
diabetic checkup during the study period were enrolled in the 
study. All socio-demographic and clinical data were taken after 
obtaining an informed written consent from each DM patient 
with or without symptoms of UTI. Patients treated with antibi-
otics within the preceding 2 weeks, and known anatomic and 
neurologic urinary tract abnormalities, also diabetic pregnant 
women were excluded from the study. 
Sample collection
Clean-catch mid- stream urine samples (5-10 mL) were obtained 
from each patient in a sterile screw-capped wide-mouth contain-
er after informing them about proper urine collection methodi. 
The containers were labeled with a unique sample number, date 
and time of collection. The urine samples were processed within 
an hour after collection in the microbiology laboratory of Ha-
wassa University Training and Research Hospital 
Culture and identification of bacterial species
Urine samples were directly inoculated on blood agar, mannitol 
salt agar and MacConkey agar plate (Oxoid, Ltd., Basingstoke, 
and Hampshire, England), using calibrated loops each deliver-
ing 0.002 mL of urine. Streaked culture plates were incubated 
under aerobic conditions at 37oc for 24 hours. On the next day, 
the bacterial growth on the respective media was controlled, and 
total colony count was calculated. Urine culture was consid-
ered significant bacteriuria (SB) when for a single isolated uro-
pathogen colony forming units (CFUs) were ≥105/mL of voided 
urine. However, ≥103 CFU/mL was considered SB for group B 
streptococcus.[18] A single colony was picked and suspended in 
nutrient broth, and then subcultured onto either blood agar or 
MacConkey agar plate and finally incubated at 370c for further 
identification. Pure isolates of bacterial pathogen were priorly 
characterized by colony morphology and gram-stain. Further 
identification was done by their colony characteristic appear-
ance on their respective media and pattern of biochemical reac-
tion using the standard procedure.[19]
Antibiotic susceptibility test
Antibiotic susceptibility testing was performed using Kirby-
Bauer disc diffusion method.[20] Bacterial suspension was pre-
pared using nutrient broth by peaking-up 3-5 colonies from pure 
culture and adjusted to 0.5 Mc-Farland standard equal to 108 
cells/mL and swab inoculated onto Mueller-Hinton Agar (Ox-
oid, Ltd., Basingstoke, and Hampshire, England). Antibiotic im-
pregnated discs were placed onto the surface of culture medium 
using an automated disc dispenser. The isolates were tested 
for ampicillin (AMP) (10 μg), amoxicillin (20 μg)-clavulanic 
acid (10 μg) (AMC) (30 μg), ceftriaxone (CRO) (30 μg), cip-
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rofloxacin (CIP) (5 μg), norfloxacin (10 μg), nitrofurantoin 
(300 μg), gentamicin (CN) (10 μg), and oxacillin (OX) (1 μg), 
sulfamethoxazole+trimethoprim (SxT) (25 μg) and penicillin 
(G) (10 IU) (Oxoid, Ltd., Basingstoke, and Hampshire, Eng-
land). After 18-24 hours of incubation at 37°C, zone of growth 
inhibition zone was measured to the nearest whole millimeter 
using a caliper. The zone of inhibition were interpreted accord-
ing to the Clinical and Laboratory Standards Institute (CLSI) 
guideline as susceptible (S), intermediate (I) or resistant (R).
[21] Quality control strains of E. coli (ATCC-25922), S. aureus 
(ATCC 25923) and P. aeruginosa (ATCC 27853), were used to 
validate the results of culture and antibiotic susceptibility test. 
Statistical analysis
The data were analyzed using the Statistical Package for the So-
cial Sciences (SPSS Inc; Chicago, IL, USA) software version 
16.0. Logistic regression analysis was done to determine the 
association between independent and dependent variables. All 
independent variables with a p- value less than or equal to 0.2 
in the bivariate analysis were included in the multivariate logis-
tic regression model to identify variables which were associated 
independently. Odds ratio (OR) within 95% confidence interval 
(CI) was calculated to measure the strength of association, and 
p-value <0.05 was considered statistically significant.
Ethical consideration 
The study was approved by the institutional review committee, 
of Hawassa University College of Medicine and Health Sci-
ences. After obtaining an informed written consent socio-demo-
graphic and clinical data were obtained from each DM patients. 
All data obtained in the course of the study were kept confiden-
tial and used exclusively for the purpose of the study. The labo-
ratory findings of study participants were communicated with 
the responsible clinicians assigned at diabetic clinic and treated 
accordingly. 
Results
Socio-demographic characteristics 
A total of 240 patients with DM were investigated for UTIs. Of 
these, 188(78.3%) patients had no symptoms of UTIs (asymp-
tomatic UTI) and the remaining 52 (21.7%) cases presented with 
symptoms of UTIs (symptomatic UTI). Sixty seven (27.9%) had 
type I and 173 (72.1%) type II DM. Majority of the patients were 
male 146 (60.8%) and the remaining 94 (39.2%) were female 
with male to female ratio of 1.55:1. The mean age of the patients 
was 44.2±16.3 years(range, 15 -86) years (Table 1).
Significant bacteriuria and associated risk factors 
The overall prevalence of diabetic UTI was 33 (13.8%). In 12 
(23.1%) symptomatic and 21 (11.2%) asymptomatic diabetic 
patients SB was isolated. All patients had not any previous his-
tory of catheterization and hospitalization. In bivariate logistic 
regression analysis, the distribution of UTI was shown to be in-
fluenced by sex, level of education, current symptoms of UTI 
and history of previous UTI. However, blood glucose level had 
borderline significant association with UTI. Other factors such 
as age, previous antibiotic usage, type of diabetes and duration 
of diabetes were not associated with UTI (Table 2). 
In multivariate logistic regression analysis, previous history of 
UTI and level of education were statistically significant. DM 
patients without any previous history of UTI [AOR=3.55; 95% 
CI=1.186-10.611 p=0.024] had higher odds of SB compared with 
those who had previous history of UTI. Similarly, DM patients 
who are illiterate [AOR=2.5; 95% CI=1.052-5.989; p=0.038] had 
higher odds of SB compared with those who are literate. While, 
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Table 1. Socio-demographic characteristics of diabetic 
patients investigated for UTIs.
 Total  Symptomatic Asymptomatic 
 (n=240) Diabetic patient Diabetic patient 
Characteristics n (%)  (n=52) n (%) n (%)
Age (years)   
15-20 26 (10.8) 1 (1.9) 25 (13.3)
21-40 74 (30.8) 16 (30.8) 58 (30.9)
41-60 109 (45.4) 28 (53.8) 81 (43.1)
61-86 31 (13.0) 7 (13.5) 24 (12.8)
Sex    
Male  146 (60.8) 26 (50.0) 120 (63.8)
Female  94 (39.2) 26 (50.0) 68 (36.2)
Education    
Illiterate  52 (21.7) 13 (25.0) 39 (20.7)
Literate  188 (78.3) 39 (75.0) 149 (79.3)
Type of diabetes   
Type I 67 (27.9) 6 (11.5) 61 (32.4)
Type II 173 (72.1) 46 (88.5) 127 (67.6)
History of UTI   
Yes  22 (9.2) 14 (26.9) 8 (4.3)
No  218 (90.8) 38 (73.1) 180 (95.7)
History of antibiotic Rx   
Yes  17 (7.1) 9 (17.3) 8 (4.3)
No  223 (92.9) 43 (82.7) 180 (95.7)
Duration of diabetes   
<5 years  135 (56.2) 24 (46.2) 111 (59.0)
≥5 years  105 (43.8) 28 (53.8) 77 (41.0)
Blood glucose level (mg/dL)  
<126 88 (36.7) 17 (32.7) 71 (37.8)
≥126 152 (63.3) 35 (67.3) 117 (62.2)
Rx: treatment; UTI: urinary tract infection; n: number of patients 
patients with blood glucose level of ≥126 mg/dL [AOR=0.402; 
95% CI=0.161-1.001; p=0.050] were less likely to develop UTI 
compared with blood glucose level ≤126 mg/dL, with borderline 
significant association. However, sex and current symptoms of 
UTI didn’t show significant association with SB (Table 2).
Isolated uropathogens 
Seven different bacterial species were isolated from 33 diabetic 
symptomatic (n=21; 63.4 %), and asymptomatic (n=12; 36.4 %) 
patients without any significant difference in the isolation fre-
quency of each pathogen between two groups (p=0.199). The 
overall predominant bacterial isolate was Escherichia coli in 11 
(33.3%) followed by CoNS in 8 (24.2%), Staphylococcus aure-
us in 6 (18.2%), Klebsiella spp in 3 (9.1%) , Citrobacter spp and 
β-hemolytic streptococci in 2 (6.1%) patients. The least preva-
lent bacterium was Pseudomonas aeruginosa in 1 (3%) which 
was isolated only in asymptomatic diabetic patients. E. coli was 
the most commonly isolated bacteria in both asymptomatic 6 
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Table 2. Association of independent variables with UTI among diabetic patients by logistic regression analysis.
                                    UTI  
Variables Yes n (%) No n (%) COR (95% CI) AOR (95% CI) p
Age (years)     
 15-20 5 (19.2) 21 (80.8) 1  
 21-40 11 (14.9) 63 (85.1) 1.364 (0.425-4.380)  
 41-60 10 (9.2) 99 (90.8) 2.357 (0.730-7.612)  
 61-86 7 (22.6) 24 (77.4) 0.816 (0.225-2.961)  
Sex      
Male  14 (9.6) 132 (90.4) 1 1 
Female  19 (20.2) 75 (79.8) 0.419 (0.199-0.883)* 0.582 (0.255-1.332) 0.200
Education      
Literate  20 (10.8) 168 (89.4) 1 1 
Illiterate 13 (25.0) 39 (75.0) 2.800 (1.283-6.110)* 2.510 (1.052-5.989) 0.038
Current symptom of UTI      
   Yes 12 (23.1) 40 (76.9) 1  
   No 21 (11.2) 167 (88.8)- 2.386 (1.084-5.250)* 1.479 (0.598-3.660) 0.397
History of UTI     
Yes 8 (36.4) 14 (63.6) 1 1 
No 25 (11.5) 193 (88.5) 4.411 (1.683-1.561)* 3.547 (1.186-10.611) 0.024
History of antibiotic Rx     
Yes 2 (11.8) 15 (88.2) 1  
No 31 (13.9) 192 (86.1) 0.826 (0.180-3.789)  
Type of diabetes     
Type I 10 (14.9) 57 (85.1) 1  
Type II 23 (13.3) 150 (86.7) 1.144 (0.513-2.553)  
Duration of diabetes     
<5 years  17 (12.6) 118 (87.4) 1  
≥5 years  16 (15.2) 89 (84.8) 0.801 (0.384-1.673)  
Blood glucose 
level (mg/dL)     
<126 7 (8.0) 81 (92.0) 1  
≥126 26 (17.1) 126 (82.9) 0.419 (0.174-1.010)** 0.402 (0.161-1.001) 0.050
Rx: treatment; UTI: urinary tract infection; COR: crude odds ratio; AOR: adjusted odds ratio; n: number of patients;*p<0.05; **p=0.05
(28.6%) and symptomatic 5 (41.7%) diabetic patients, followed 
by CoNS in 5 (23.8%) and in 3 (25%) patients, respectively 
(Table 3). Four urine samples out of 240 (1.7%) demonstrated 
candidial growth. 
Antibiotic resistance pattern 
Antibiotic resistance patterns of Gram- negative bacteria to vari-
ous antibiotics was shown in Table 4. Gram- negative isolates 
showed 100% resistance against ampicillin and high percent-
age (82.4%), of resistance to trimethoprim-sulphamethoxazole, 
ceftriaxone (64.7%), gentamicin (58.8%) and amoxicillin-cla-
vulanic acid (41.2%). However, 100% of the isolated Gram-neg-
ative bacteria were susceptible to nitrofurantoin. Among Gram- 
negative bacteria, the predominant isolate was E. coli, (64.7% of 
Gram- negatives, 33.3% of all isolates) which showed 100 % re-
sistance to ampicillin, followed by trimethoprim-sulphamethox-
azole (81.8%), gentamicin (72.7%), ceftriaxone (63.6%), amox-
icillin-clavulanic acid (36.4%) and ciprofloxacin (18.2%). Low 
resistance to norfloxacin (9.1%) was observed. However, 100% 
of the isolated E. coli was susceptible to nitrofurantoin (Table 4). 
The antibiotic resistance pattern of Gram- positive bacteria to 
various antibiotics was shown in Table 5. Similarly, Gram- posi-
tive isolates were 100% resistant to ampicillin and 100% sensi-
tive to nitrofurantoin. High percentage of resistance to penicillin 
(87.5%) norfloxacin (62.5%), ciprofloxacin (50.0%), trime-
thoprim-sulphamethoxazole (43.75%) and a nearly 25% resis-
tance to ceftriaxone, amoxicillin-clavulanic acid and oxacillin 
were observed. However, 87.5% of Gram- positive bacteria 
were sensitive to gentamicin. Coagulase- negative staphylococci 
were the most predominant isolate among Gram-positive bacte-
ria in 8 (50%) and the second most predominant pathogen of all 
isolates in 8 (24.2%) patients which showed 100% resistance to 
ampicillin and penicillin followed by norfloxacin 6 (75%), and 
ciprofloxacin 4 (50.0%). However, 100% of the isolated CoNS 
were sensitive to nitrofurantoin and gentamicin (Table 5). 
The overall multidrug resistance (MDR ≥two antimicrobial 
agents) was observed in 31 out of 33 (93.9%) bacterial isolates. 
While, 2 (6.1%) of the isolates were resistant to one antibiotic. 
There was no isolate sensitive and resistant to all the antibiotic 
agents tested (Table 6).
Discussion
The risk of developing antibiotic resistance in diabetes -asso-
ciated UTI is a major concern in developing countries where 
urine culture is not routinely performed. In this study, overall 
prevalence of diabetic UTI was 13.8%. DM patients without 
any previous history of UTI had higher odds of contracting UTI 
compared with those who had previous history of UTI. Simi-
larly, illiterate patients had higher odds of getting UTI compared 
with those who are literate. E. coli was the commonest isolated 
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Table 4. Antimicrobial resistance patterns of gram-negative bacteria isolated from urine cultures of diabetic patients.
Bacterial Isolates Total No  S/R AMP AMC CRO CIP NOR NIF CN SxT
E. coli 11 S 0 7 (63.6) 4 (36.4) 9 (81.8) 10 (90.9) 11 (100) 3 (27.3) 2 (18.2)
  R 11 (100) 4 (36.4) 7 (63.6) 2 (18.2) 1 (9.1) 0 8 (72.7) 9 (81.8)
Klebsiella spp 3 S 0 1 (33.3) 1 (33.3) 1 (33.3) 1 (33.3) 3 (100) 2 (66.7) 0
  R 3 (100) 2 (66.7) 2 (66.7) 2 (66.7) 2 (66.7) 0 1 (33.3) 3 (100)
Citrobacter spp 2 S 0 2 (100) 1 (50) 2 (100) 2 (100) 2 (100) 2 (100) 1 (50)
  R 2 (100) 0 1 (50) 0 0 0 0 1 (50)
P. aeruogenosa 1 S 0 0 0 1 (100) 1 (1000 1 (100) 0 0
  R 1 (100) 1 (100) 1 (100) 0 0 0 1 (100) 1 (100)
Total  17 S 0 10 (58.8) 6 (35.3) 13 (76.5) 14 (82.4) 17 (100) 7 (41.2) 3 (17.6)
  R 17 (100) 7 (41.2) 11 (64.7) 4 (23.5) 3 (17.6) 0 10 (58.8) 14 (82.4)
AMP: ampicillin; AMC: amoxicillin-clavulanic acid; CRO: ceftriaxone; CIP: ciprofloxacin; NIF: nitrofurantoin; NOR: norfloxacin; CN: gentamicin; SxT: trimethoprim-sulphamethoxazole
Table 3. Distribution of the causative agents of asymptomatic 
and symptomatic UTI among diabetic patients
 Asymptomatic  Symptomatic   
Uropathogen UTI UTI Total
Isolated No (%) No (%) No (%)
E. coli 6 (28.6) 5 (41.7) 11 (33.3)
CoNS  5 (23.8) 3 (25.0) 8 (24.2)
S. aureus 5 (23.8) 1 (8.3) 6 (18.2)
Klebsiella spp, 1 (4.8) 2 (16.7) 3 (9.1)
β.H. streptococci 2 (9.5) 0 2 (6.1)
Citrobacter spp 1 (4.8) 1 (8.3) 2 (6.1)
P. aeruogenosa 1 (4.8) 0 1 (3.0)
Total  21 (63.6) 12 (36.4) 33 (100)
Coagulase- negative Staphylococci β.HS: Beta Hemolytic streptococc
uropathogen and all the isolated bacteria were 100%, resistant to 
ampicillin and 100 % sensitive to nitrofurantoin.
In this study, the prevalence of diabetic-associated UTI was 
13.8%. This finding is comparable with other findings in Ad-
dis Ababa (10.4-14%)[10,11] and Gondar (17.8%)[9], Ethiopia and 
Nigeria (17.3%).[22] However, this finding was lower as com-
pared to the studies conducted in Nepal (21%)[23] and Germany 
(22.5%).[12] The variation in prevalence might be explained by 
difference in geography, the host factor and practices such as, 
social habits of the community, standards of personal hygiene 
and health education practices.
In this study, DM patients with no previous history of UTI had 
higher odds of contracting UTI compared with those who had 
previous history of UTI which showed contradictory results 
relative to previous studies conducted within the country[9] and 
other parts of the world[8]. The possible reason might be due to 
recall bias of patients. But it needs future advanced research to 
corroborate these findings. In addition, illiterate study partici-
pants had higher odds of getting UTI compared with those who 
are literate. Although, the association was borderline significant, 
patients with fasting blood glucose level of ≥126 mg/dL were 
less likely to have significant bacteriuria compared with patients 
who have <126 mg/dL. However, the previous study in Gon-
dar[9] reported a significant correlation between hyperglycemia, 
and UTI. This indicates instataneous determination of fasting 
blood glucose level may not be associated with bacteriuria. Fur-
ther large scale and glucose level follow-up studies are needed 
to conclude whether fasting blood glucose level is associated 
with significant bacteriuria or not. 
The predominant uropathogen detected both in asymptomatic 
and symptomatic UTIs in this study was E. coli concordant with 
studies done in Ethiopia[9-11] and elsewhere.[12,13,22-25] This may be 
due to much stronger adherence of virulent type 1-fimbriated E. 
coli to the uroepithelial cells of diabetic patients.[26] The second 
most common isolated uropathogen was CoNS in conformity 
with a study conducted in Gondar.[9] However, this is in con-
trast to other studies; where Klebsiella species was the second 
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Table 5. Antimicrobial resistance patterns of Gram- positive bacteria isolated from urine culture of diabetic patients
Bacterial   Total  
Isolates no  S/R AMP AMC CRO CIP NOR NIF CN SXT PG OX
CoNS  8 S - 6 (75) 5 (62.5) 4 (50) 2 (25) 8 (100) 8 (100) 5 (62.5) 0 5 (62.5)
  R 8 (100) 2 (25) 3 (32.5) 4 (50) 6 (75) 0 0 3 (32.5) 8 (100) 3 (32.5)
S. aureus 6 S - 4 (66.7) 5 (83.3) 3 (50) 3 (50) 6 (100) 6 (100) 4 (66.7) 0 5 (83.3)
  R 6 (100) 2 (33.3) 1 (17.7) 3 (50) 3 (50) 0 0 2 (33.3) 6 (100) 1 (17.7)
β.HS 2 S - 2 (100) 2 (100) 1 (50) 1 (50) 2 (100) 0 0 2 (100) 2 (100)
  R 2 (100) 0 0 1 (50) 1 (50) 0 2 (100) 2 (100) 0 0
Total 16 S - 12 (75) 12 (75) 8 (50) 6 (37.5) 16 (100) 14 (87.5) 9 (56.25) 2 (12.5) 12 (75)
  R 16 (100) 4 (25) 4 (25) 8 (50) 10 (62.5) 0 2 (12.5) 7 (43.75) 14 (87.5) 4 (25)
AMP: ampicillin; AMC: amoxicilin + clavulanic acid; CRO: ceftriaxone; CIP: ciprofloxacin; NIF: nitrofurantoin; NOR: norfloxacin; CN: gentamicin; SxT: trimethoprim-
sulphamethoxazole; PG: penicillin; OX: oxacillin Coagulase- negative Staphylococci β.HS: Beta Hemolytic streptococci
Table 6. Multiple antibiotic resistance patterns of bacterial isolates from urine culture of diabetic patients
  Antibiogram patterns  
Organisms  No (%) R1 R2 R3 R4 R5 R6 R7
S. aureus  6 (18.2) 0 2 (33.3) 1 (16.7) 0 1 (16.7) 2 (33.3) 0
CoNS 8 (24.2) 0 1 (12.5) 2 (25) 1 (12.5) 1 (12.5) 1 (12.5) 2 (25)
β.HS 2 (6.1) 0 0 1 (50) 0 1 (50) 0 0
E. coli 11 (33.3) 1 (9.1) 1 (9.1) 2 (18.2) 2 (18,2) 3 (27.3) 2 (18.2) 0
Klebsiella spp 3 (9.1) 0 0 0 1 (33.3) 1 (33.3) 1 (33.3) 0
Citrobacter spp 2 (6.1) 1 (50) 0 1 (50) 0 0 0 0
P. aeruogenosa 1 (3) 0 0 0 0 1 (100) 0 0
Total  33 (100) 2 (6.1) 4 (12.1) 7 (21.2) 4 (12.1) 8 (24.2) 6 (24.2) 2 (6.1)
R1, R2, R3, R4, R5, R6,R7 resistance to one, two, three, four, five, six, seven antimicrobials tested, Coagulase- negative Staphylococci β.HS: Beta Hemolytic streptococci
most common isolated uropathogen.[11,22-25] High isolation rate of 
CoNS in this study might be explained by contamination during 
specimen collection or processing and/or a possible change in 
pattern of infection in DM patients.[9] 
According to the Ethiopian standard treatment guideline[27], 
trimethoprim-sulphamethoxazole is the first- line drug while, 
norfloxacin or amoxicillin is an alternative drug for the empiric 
treatment of uncomplicated UTI. In this study, Gram-negative 
bacteria showed high resistance to ampicillin, trimethoprim-
sulphamethoxazole, ceftriaxone, gentamicin and amoxicillin-
clavulanic acid. This result coincides with results reported from 
different part of the country[9,15,28,29] except the degree of resis-
tance was higher in our cases. Even if the resistance rate and 
usage of drug is complicated; the cause of resistance for these 
drugs in this hospital might be deviation from the WHO stan-
dard prescription practices[30] which provide an environment or 
selection of resistant bacteria.
In this study, the higher resistance of Gram- negative bacteria 
to trimethoprim-sulphamethoxazole (82.7%) was demonstrated 
in agreement with a study conducted in Ethiopia[9,28,29] and else-
where.[13,22] Studies had also proposed that due to emergence of 
high antimicrobial resistance and hypoglycemia, this antibiotic 
cannot be used as an empirical therapy for urinary tract infec-
tions among DM patients.[31] Indeed, emphasis should be given 
while developing treatment guideline. Although, Gram-negative 
isolates were susceptible to fluoroquinolones as ciprofloxacin 
and norfloxacin, more than half of the isolated Gram-positive 
bacteria were resistant to these antibiotics. This finding ques-
tions the usefulness of fluoroquinolone for the empiric treatment 
of UTI. However, all of isolated uropathogens were susceptible 
to nitrofurantoin. This is comparable with other studies.[5,29] 
Thus, nitrofurantoin can be used as drug of choice for empiric 
treatment of UTI in the study area.
In this study, 93.9% of the isolated uropathogens showed MDR 
against two and more antimicrobial agents tested. This finding 
is comparable with findings reported in Gondar (91.7%-95%)
[15] and Addis Ababa (92.34%).[29] However, this incidence rate 
is higher than the findings of other studies conducted in Gondar 
(59.8%)[9] and Addis Ababa (71.7%).[10] The reason for high in-
cidence of MDR might be patients’ poor adherence to prescribed 
antibiotics, irrational use of antimicrobials, over-the-counter 
availability of antibiotics[16] and circulation of plasmid borne[32] 
high level drug resistant uropathogen in the study area. 
Nevertheless, this study has some limitations regarding interpre-
tation of its results. First, as a hospital- based study that used a 
non-probability sampling method, selection bias may be intro-
duced that hinder the generalizability of the results to all DM 
patients in the study area. Second, because of lack of resource 
tests evaluating HBA1c and immunologic function like cytokine 
production and neutrophil function could not be performed. 
In conclusion, the overall prevalence of diabetic UTI was 13.8%. 
DM patients with no previous history of UTI had higher odds of 
contracting UTI compared with those who had previous history 
of UTI. Similarly, those who are illiterate had higher odds of 
getting UTI compared with their counterparts. E. coli was the 
most common isolated uropathogen followed by CoNS. All iso-
lated bacteria were 100% resistant to ampicillin and 100% sen-
sitive to nitrofurantoin. Multidrug resistance to commonly used 
antibiotics in the study area is alarming. Therefore, performing 
urine culture and periodic surveillance of UTI on DM patients 
is necessary.
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